262049 Tobacco cessation for individuals in alcohol or substance abuse treatment or recovery

Tuesday, October 30, 2012 : 5:10 PM - 5:30 PM

Dorothy Apollonio, PhD MPP , Department of Clinical Pharmacy, UCSF, San Francisco, CA
Lisa Bero, PhD , Department of Clinical Pharmacy, UCSF, San Francisco, CA
There has been increasing attention to the problem of tobacco addiction in individuals in substance abuse treatment and recovery, as these individuals experience smoking rates much higher than the general population, and as a consequence suffer dramatically more associated tobacco-related disease. We update and expand on a meta-analysis completed in 2004 that assessed the effectiveness of tobacco cessation treatment for individuals in alcohol and substance abuse treatment and recovery. Despite increasing demand for tobacco cessation treatment in substance abuse treatment, reflecting the high rates of smoking and tobacco-related disease in this population, there has been limited systematic assessment of the effectiveness of such treatment or efforts to target trials to under-researched populations. The findings of this review will inform the design of future studies of tobacco cessation treatment as well as provide an assessment of whether the provision of tobacco cessation treatment in these populations should be the standard of care.

Learning Areas:
Administer health education strategies, interventions and programs
Clinical medicine applied in public health
Planning of health education strategies, interventions, and programs
Provision of health care to the public
Public health or related research

Learning Objectives:
Identify smoking rates in populations with addictions Assess the effectiveness of tobacco cessation interventions for individuals in substance abuse treatment or recovery

Keywords: Tobacco Control, Methodology

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been the principal of multiple grants and author of multiple articles dealing with tobacco control.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.